CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Multiple myeloma derived sulfur dioxide drives CAR-T cell exhaustion by inducing mitochondrial dysfunction.
Multiple myeloma derived sulfur dioxide drives CAR-T cell exhaustion by inducing mitochondrial dysfunction.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
由代谢紊乱介导的嵌合抗原受体(CAR)T细胞耗竭会损害癌症免疫治疗。由L-半胱氨酸催化产生的内源性二氧化硫(SO₂)可调节免疫细胞功能,但其在CAR-T 细胞耗竭中的作用此前未知。
本研究发现,复发性多发性骨髓瘤患者骨髓微环境中SO₂蓄积会抑制CD8⁺ T细胞和CAR-T 细胞浸润,并促进符合功能耗竭特征的转录谱,导致抗肿瘤免疫受损。肿瘤细胞来源的SO₂可改变CAR-T 细胞线粒体形态并破坏线粒体膜电位,同时损害细胞因子分泌和细胞毒功能。在机制层面,SO₂通过DRP1在半胱氨酸607(Cys607)位点发生亚磺化,增强动力相关蛋白1(DRP1)与电压依赖性阴离子通道1的相互作用及线粒体分裂;DRP1 GTP酶活性异常升高,破坏线粒体完整性。在CAR-T 细胞中对Cys607位点进行突变,可消除DRP1亚磺化,恢复线粒体结构并改善抗肿瘤免疫。这些发现揭示了一种新的氧化还原介导CAR-T 细胞线粒体功能障碍和耗竭的机制,并指出SO₂-DRP1轴可能是克服CAR-T 治疗代谢性耗竭的潜在靶点。
Metabolic disorders mediated chimeric antigen receptor - T cell (CAR-T) exhaustion impaired cancer immunotherapy. Endogenous sulfur dioxide (SO 2 ) derived from L-cysteine catalysis regulated immune cell functions.
However, its role in CAR-T cell exhaustion remained unknown. In this study, we identified that SO 2 accumulated in the bone marrow microenvironment of relapsed multiple myeloma patients inhibited CD8 + T cell and CAR-T cell infiltration and promoted a transcriptional profile consistent with functional exhaustion, leading to impaired antitumor immunity. Tumor cell derived SO 2 altered mitochondrial morphology and disrupted mitochondrial membrane potential in CAR-T cells, accompanied by impaired cytokine secretion and loss of cytotoxic function.
Mechanistically, SO 2 enhanced interaction of dynamin-related protein 1 (DRP1) and voltage-dependent anion channel 1 and mitochondrial fission via DRP1 sulphenylation at cysteine 607 (Cys607), with abnormal increases in DRP1 GTPase activity, disrupting mitochondrial integrity. Site mutation of Cys607 in CAR-T cells abrogated DRP1 sulphenylation and restored mitochondrial structure and improves antitumor immunity.
These findings define a novel redox-mediated mechanism of mitochondrial dysfunction in CAR-T cells exhaustion and identify the SO 2 -DRP1 axis as a potential therapeutic target to overcome metabolic exhaustion in CAR-T cell therapy.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。